Sign in

CIK 0001158780

  • Non-accelerated filer
  • Smaller reporting company
Ticker
PLUR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Jun 30
Incorporated
NV
Entity type
Operating
EIN
980351734
Phone
+972 747107171
Business address
MATAM ADVANCED TECHNOLOGY PARK, BUILDING NO. 5, HAIFA, Israel
Former names
PLURISTEM THERAPEUTICS INC, PLURISTEM LIFE SYSTEMS INC, AI SOFTWARE INC
Open-market buys, last 90 days
$1,250,001
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$1,250,001. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Manieu Alexandre Weinstein +$1.3M Director 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-12-04 Aberman Zami Director Grant or award +346 144,212
2025-02-25 Aberman Zami Director Grant or award +14,350 143,866
2024-01-23 Aberman Zami Director Grant or award +44,100 1,536,073
2022-12-20 Aberman Zami Director Sale −2,000 $0.97 $2K 1,491,973
2022-02-10 Aberman Zami Director Purchase +80,616 $1.80 $145K 91,756
2020-09-10 Aberman Zami Executive Chairman Grant or award +500,000 993,973
2020-09-10 Aberman Zami Executive Chairman Grant or award +500,000 1,493,973
2019-04-08 Aberman Zami Co-CEO & Chairman Purchase +71,429 $0.70 $50K 4,939,727
2019-04-08 Aberman Zami Co-CEO & Chairman Purchase · Common Stock Warrant +71,429 71,429
2018-12-19 Aberman Zami Co-CEO & Chairman Grant or award +300,000 4,618,298
2018-12-19 Aberman Zami Co-CEO & Chairman Grant or award +250,000 4,868,298
2017-06-21 Aberman Zami Co-CEO & Chairman Grant or award +2,000,000 4,318,298
2016-12-29 Aberman Zami CEO & Chairman Grant or award +200,000 2,318,298

Page 1 of 1 · 13 trades